(Q47149241)

English

Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

scientific article published in December 2010

In more languages

Statements

scholarly article

0 references

Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 (English)

0 references

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

EFSA Panel On Dietetic Products, Nutrition And Allergies

1

object named as

Efsa Panel On Dietetic Products, Nutrition And Allergies (nda)

0 references

publication date

December 2010

0 references

0 references

8

0 references

12

0 references

1885

0 references

Diet, lifestyle, and nonstatin trials: review of time to benefit

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Scientific Opinion on the substantiation of health claims related to beta glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) p...

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Oat bran concentrate bread products improve long-term control of diabetes: a pilot study

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Oat products and lipid lowering. A meta-analysis

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Processing affects the physicochemical properties of beta-glucan in oat bran cereal

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

The evidence for dietary prevention and treatment of cardiovascular disease

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1885

21 January 2018

Identifiers

10.2903/J.EFSA.2010.1885

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47149241&oldid=1631943738"